
Medicine overview
Indications of Maxnor 4 mg/4 ml
Theropeutic Class
Pharmacology
Dosage & Administration of Maxnor 4 mg/4 ml
Interaction of Maxnor 4 mg/4 ml
Contraindications
Side Effects of Maxnor 4 mg/4 ml
Pregnancy & Lactation
Precautions & Warnings
Overdose Effects of Maxnor 4 mg/4 ml
Storage Conditions
Reconstitution
Frequently Asked Questions
What is Maxnor 4 mg/4 ml used for?
For blood pressure control in certain acute hypotensive states (e.g., pheochromocytomectomy, sympathectomy, poliomyelitis, spinal anesthesia, myocardial infarction, septicemia, blood transfusion, and drug reactions). As an adjunct in the treatment of cardiac arrest and profound hypotension.
What is the dosage of Maxnor 4 mg/4 ml?
Upper gastrointestinal haemorrhage: Adult: Intraperitoneal admin: 8 mg in 250 ml of 0.9% sodium chloride inj. Alternatively, instill 8 mg in 100 ml of 0.9% sodium chloride solution through a nasogastric tube every hr for 6–8 hr, then every 2 hr for 4–6 hr. Withdraw drug gradually. Acute hypotensive states: Adult: Initially, 8-12 mcg/minute, up to 8-30 mcg/minute in refractory shock. Infuse using a…
What are the side effects of Maxnor 4 mg/4 ml?
Hypertension, headache, peripheral ischaemia, bradycardia, arrhythmias, anxiety, skin necrosis (with extravasation), dyspnoea, respiratory difficulty.
Who should not take Maxnor 4 mg/4 ml?
Hypertension. Pregnancy. Patients with peripheral or mesenteric vascular thrombosis unless necessary as a life-saving procedure.
What precautions should be taken with Maxnor 4 mg/4 ml?
Not a substitute for replacement of blood, plasma, fluids, and/or electrolytes; correct volume depletion prior to admin. Identify and correct hypoxia, hypercapnia and acidosis prior to or during admin. Avoid extravasation as tissue necrosis may occur. Avoid inj into leg veins, especially in elderly or those with occlusive vascular diseases, arteriosclerosis, DM or Buerger's disease. Hypertensive o…
Is Maxnor 4 mg/4 ml safe during pregnancy and breastfeeding?
Pregnancy Category C. Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus.
The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.